Firmenbeschreibung
Die Marinomed Biotech AG ist ein österreichisches biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer Produkte im Bereich Atemwegs- und Augenerkrankungen spezialisiert, die auf patentgeschützter Technologieplattformen basieren. Das Unternehmen ging 2006 aus einem Spinoff der Veterinärmedizinischen Universität Wien hervor. Die Marinomed Biotech AG ist in der Forschung und Entwicklung tätig und erwirtschaftet Erlöse über die Technologieplattformen und dem Vertrieb der Produkte. Das Unternehmen entwickelte bisher die Plattform Carragelose® sowie die Marinosolv®-Technologieplattform. Carragelose® wird in verschiedenen Produkten zur Behandlung von viralen Infektionen der Atemwege eingesetzt, die nahezu weltweit über Partner vertrieben werden. Mit Marinosolv® kann die Wirksamkeit schwer löslicher Wirkstoffe verbessert werden.
KeyData
| endOfFinancialYear: | 31.12.2022 00:00 |
| stockholderStructure: | Free float (69.4%),Andreas Grassauer CEO (7.4%),Eva Prieschl-Grassauer CSO (7.4%),Herman Unger (7%),Abdulmohsen Al Sheikh (4.4%),Mohammed Al Sheikh (4.4%) |
| sharesOutstanding: | 1778333.0000 |
| ceo: | Andreas Grassauer |
| board: | Pascal Schmidt, Eva Prieschl-Grassauer |
| supervisoryBoard: | Simon Nebel, Brigitte Ederer, Elisabeth Lackner, Ulrich Kinzel, Eva Hofstaedter-Thalmann |
| countryID: | 1 |
| faceValue: | 1.0000 |
| faceValueCurrencyID: | 1 |
| faceValueCurrency: | EUR |
| sectorName: | Pharmazeutische Industrie |
| industryName: | Gesundheitswesen |
| subsectorName: | Pharmazeutische Industrie |
| country: | Österreich |
| countryName: | Österreich |
Kontakt
| name: | Stephanie Kniep |
| email: | ir@marinomed.com |
| irWebSite: | https://www.marinomed.com/en/investors-esg/share-information |
Adresse
| street: | Hovengasse 25 |
| city: | A-2100 Korneuburg |
| phone: | +43-2262-90300 |
| webSite: | https://www.marinomed.com/de/ |
| email: | office@marinomed.com |
Finanzen (kurz)
| year: | 2022 | cash: | 8.2000 |
| balanceSheetTotal: | 22.3000 | liabilities: | 26.5000 |
| totalShareholdersEquity: | -4.1500 | sales: | 11.2700 |
| investment: | 1.2000 | incomeBeforeTaxes: | -6.4000 |
| netIncome: | -6.4000 | employees: | 49 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
| year: | 2023 | cash: | 2.5800 |
| balanceSheetTotal: | 14.6100 | liabilities: | 24.7400 |
| totalShareholdersEquity: | -10.1300 | sales: | 9.1800 |
| investment: | 0.8600 | incomeBeforeTaxes: | -6.7900 |
| netIncome: | -6.7940 | employees: | 52 |
| currencyID: | 1 | units: | 1000000 |
| currency: | EUR |
| year: | 2024 | cash: | 1.7060 |
| balanceSheetTotal: | 8.1830 | liabilities: | 34.3410 |
| totalShareholdersEquity: | -26.1580 | sales: | 4.7460 |
| incomeBeforeTaxes: | -15.5150 | netIncome: | -15.4160 |
| employees: | 47 | currencyID: | 1 |
| units: | 1000000 | currency: | EUR |
Finanzen (kurz)
| year: | 2022 |
| cash: | 8.2000 |
| balanceSheetTotal: | 22.3000 |
| liabilities: | 26.5000 |
| totalShareholdersEquity: | -4.1500 |
| sales: | 11.2700 |
| investment: | 1.2000 |
| incomeBeforeTaxes: | -6.4000 |
| netIncome: | -6.4000 |
| employees: | 49 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
| year: | 2023 |
| cash: | 2.5800 |
| balanceSheetTotal: | 14.6100 |
| liabilities: | 24.7400 |
| totalShareholdersEquity: | -10.1300 |
| sales: | 9.1800 |
| investment: | 0.8600 |
| incomeBeforeTaxes: | -6.7900 |
| netIncome: | -6.7940 |
| employees: | 52 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
| year: | 2024 |
| cash: | 1.7060 |
| balanceSheetTotal: | 8.1830 |
| liabilities: | 34.3410 |
| totalShareholdersEquity: | -26.1580 |
| sales: | 4.7460 |
| incomeBeforeTaxes: | -15.5150 |
| netIncome: | -15.4160 |
| employees: | 47 |
| currencyID: | 1 |
| units: | 1000000 |
| currency: | EUR |
Finanzen (ausführlich)
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 14.6100 | cash: | 2.5800 |
| currentAssets: | 7.1300 | fixedAssets: | 7.4700 |
| liabilities: | 9.6500 | nonCurrentLiabilities: | 15.0900 |
| totalLiabilitiesEquity: | 14.6100 | totalShareholdersEquity: | -10.1300 |
| employees: | 52 | property: | 5.9400 |
| intangibleAssets: | 1.5200 | inventories: | 1.0100 |
| accountsReceivable: | 3.5300 | accountsPayable: | 1.5300 |
| liabilitiesTotal: | 24.7400 | longTermDebt: | 14.8400 |
| shortTermDebt: | 6.9500 | sales: | 9.1800 |
| depreciation: | 0.6780 | netIncome: | -6.7940 |
| operatingResult: | -5.1200 | incomeInterest: | 3.3800 |
| incomeTaxes: | 0.0040 | minorityInterestsProfit: | 0.0000 |
| revenuePerEmployee: | 176538.4615 | cashFlow: | -4.5200 |
| cashFlowInvesting: | -0.1280 | cashFlowFinancing: | -0.9290 |
| accountingStandard: | IFRS | equityRatio: | -69.3361 |
| liquidityI: | 26.7358 | liquidityII: | 63.3161 |
| netMargin: | -74.0087 | cashFlowMargin: | -49.2375 |
| ebitMargin: | -55.7734 | ebitdaMargin: | 0.0000 |
| preTaxROA: | -46.4750 | roa: | -46.5024 |
| netIncomeGrowth: | 6.1562 | revenuesGrowth: | -18.5448 |
| taxExpenseRate: | -0.0589 | epsBasic: | -4.5000 |
| epsBasicGrowth: | 4.6512 | priceCashFlowRatio: | -9.8078 |
| bookValuePerShare: | -6.6724 | marketCap: | 44331264.8000 |
| earningsYield: | -15.4110 | cashFlowPerShare: | -2.9772 |
| priceBookValueRatio: | -4.3762 | netEarningsPerShare: | -4.4751 |
| currency: | EUR |
| year: | 2024 | units: | 1000000 |
| balanceSheetTotal: | 8.1830 | cash: | 1.7060 |
| currentAssets: | 3.1500 | fixedAssets: | 4.8920 |
| totalLiabilitiesEquity: | 8.1830 | totalShareholdersEquity: | -26.1580 |
| employees: | 47 | property: | 4.7880 |
| intangibleAssets: | 0.0860 | longTermInvestments: | 0.0180 |
| inventories: | 0.2640 | accountsReceivable: | 0.4180 |
| accountsPayable: | 1.6870 | liabilitiesTotal: | 34.3410 |
| shortTermDebt: | 28.2300 | sales: | 4.7460 |
| depreciation: | 1.0640 | netIncome: | -15.4160 |
| operatingResult: | -7.6000 | incomeTaxes: | -0.0990 |
| minorityInterestsProfit: | 0.0000 | revenuePerEmployee: | 100978.7234 |
| accountingStandard: | IFRS | equityRatio: | -319.6627 |
| netMargin: | -324.8209 | cashFlowMargin: | 0.0000 |
| ebitMargin: | -160.1349 | ebitdaMargin: | 0.0000 |
| preTaxROA: | -189.6004 | roa: | -188.3906 |
| netIncomeGrowth: | 126.9061 | revenuesGrowth: | -48.3007 |
| taxExpenseRate: | 0.6381 | epsBasic: | -8.6700 |
| epsBasicGrowth: | 92.6667 | bookValuePerShare: | -14.7093 |
| marketCap: | 26674995.0000 | earningsYield: | -57.8000 |
| priceBookValueRatio: | -1.0198 | netEarningsPerShare: | -8.6688 |
| currency: | EUR |
| year: | 2025 | bookValuePerShare: | -14.7093 |
| marketCap: | 21339996.0000 | earningsYield: | -72.2500 |
| pegRatio: | -0.0149 | netAssetsPerShare: | -14.7093 |
| priceBookValueRatio: | -0.8158 | netEarningsPerShare: | -8.6688 |
| currency: | EUR |
Finanzen (ausführlich)
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 14.6100 |
| cash: | 2.5800 |
| currentAssets: | 7.1300 |
| fixedAssets: | 7.4700 |
| liabilities: | 9.6500 |
| nonCurrentLiabilities: | 15.0900 |
| totalLiabilitiesEquity: | 14.6100 |
| totalShareholdersEquity: | -10.1300 |
| employees: | 52 |
| property: | 5.9400 |
| intangibleAssets: | 1.5200 |
| inventories: | 1.0100 |
| accountsReceivable: | 3.5300 |
| accountsPayable: | 1.5300 |
| liabilitiesTotal: | 24.7400 |
| longTermDebt: | 14.8400 |
| shortTermDebt: | 6.9500 |
| sales: | 9.1800 |
| depreciation: | 0.6780 |
| netIncome: | -6.7940 |
| operatingResult: | -5.1200 |
| incomeInterest: | 3.3800 |
| incomeTaxes: | 0.0040 |
| minorityInterestsProfit: | 0.0000 |
| revenuePerEmployee: | 176538.4615 |
| cashFlow: | -4.5200 |
| cashFlowInvesting: | -0.1280 |
| cashFlowFinancing: | -0.9290 |
| accountingStandard: | IFRS |
| equityRatio: | -69.3361 |
| liquidityI: | 26.7358 |
| liquidityII: | 63.3161 |
| netMargin: | -74.0087 |
| cashFlowMargin: | -49.2375 |
| ebitMargin: | -55.7734 |
| ebitdaMargin: | 0.0000 |
| preTaxROA: | -46.4750 |
| roa: | -46.5024 |
| netIncomeGrowth: | 6.1562 |
| revenuesGrowth: | -18.5448 |
| taxExpenseRate: | -0.0589 |
| epsBasic: | -4.5000 |
| epsBasicGrowth: | 4.6512 |
| priceCashFlowRatio: | -9.8078 |
| bookValuePerShare: | -6.6724 |
| marketCap: | 44331264.8000 |
| earningsYield: | -15.4110 |
| cashFlowPerShare: | -2.9772 |
| priceBookValueRatio: | -4.3762 |
| netEarningsPerShare: | -4.4751 |
| currency: | EUR |
| year: | 2024 |
| units: | 1000000 |
| balanceSheetTotal: | 8.1830 |
| cash: | 1.7060 |
| currentAssets: | 3.1500 |
| fixedAssets: | 4.8920 |
| totalLiabilitiesEquity: | 8.1830 |
| totalShareholdersEquity: | -26.1580 |
| employees: | 47 |
| property: | 4.7880 |
| intangibleAssets: | 0.0860 |
| longTermInvestments: | 0.0180 |
| inventories: | 0.2640 |
| accountsReceivable: | 0.4180 |
| accountsPayable: | 1.6870 |
| liabilitiesTotal: | 34.3410 |
| shortTermDebt: | 28.2300 |
| sales: | 4.7460 |
| depreciation: | 1.0640 |
| netIncome: | -15.4160 |
| operatingResult: | -7.6000 |
| incomeTaxes: | -0.0990 |
| minorityInterestsProfit: | 0.0000 |
| revenuePerEmployee: | 100978.7234 |
| accountingStandard: | IFRS |
| equityRatio: | -319.6627 |
| netMargin: | -324.8209 |
| cashFlowMargin: | 0.0000 |
| ebitMargin: | -160.1349 |
| ebitdaMargin: | 0.0000 |
| preTaxROA: | -189.6004 |
| roa: | -188.3906 |
| netIncomeGrowth: | 126.9061 |
| revenuesGrowth: | -48.3007 |
| taxExpenseRate: | 0.6381 |
| epsBasic: | -8.6700 |
| epsBasicGrowth: | 92.6667 |
| bookValuePerShare: | -14.7093 |
| marketCap: | 26674995.0000 |
| earningsYield: | -57.8000 |
| priceBookValueRatio: | -1.0198 |
| netEarningsPerShare: | -8.6688 |
| currency: | EUR |
| year: | 2025 |
| bookValuePerShare: | -14.7093 |
| marketCap: | 21339996.0000 |
| earningsYield: | -72.2500 |
| pegRatio: | -0.0149 |
| netAssetsPerShare: | -14.7093 |
| priceBookValueRatio: | -0.8158 |
| netEarningsPerShare: | -8.6688 |
| currency: | EUR |
